Chan Heng Fai Ambrose - Apr 3, 2025 Form 4 Insider Report for IMPACT BIOMEDICAL INC. (IBO)

Role
Director
Signature
/s/ Heng Fai Ambrose Chan
Stock symbol
IBO
Transactions as of
Apr 3, 2025
Transactions value $
-$174,020
Form type
4
Date filed
4/7/2025, 05:18 PM
Previous filing
Apr 4, 2025
Next filing
Apr 17, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBO Common stock Sale -$174K -352K -100% $0.50 0 Apr 3, 2025 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 3, 2025, Alset International Limited sold 351,555 shares of the Issuer's common stock at a weighted average sale price of $0.495. This transaction was executed in multiple trades at prices ranging from $0.46 to $0.57. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F2 Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc.